Loading...
Imipenem-cilastatin as initial therapy for febrile cancer patients.
Imipenem-cilastatin was used to treat 79 febrile episodes in 71 cancer patients, most of whom had neutropenia. The overall response rate was 67%, and 76% of the 45 documented infections responded. The response rates for septicemias and pneumonias were 79 and 62%, respectively. Only 1 of the 17 infec...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
1986
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC180520/ https://ncbi.nlm.nih.gov/pubmed/3532942 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|